Naturewise Biotech & Medicals (ROCO:4732) Total Equity: NT$640.8 Mil (As of Dec. 2025)


ROCO:4732 Naturewise Biotech & Medicals Corp ROCO:4732
63 GF Score
Price NT$17.30
GF Value NT$22.09
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Naturewise Biotech & Medicals Total Equity?

Naturewise Biotech & Medicals ROCO:4732 63 Total Equity is NT$640.8 Mil as of Dec. 2025. GuruFocus rates ROCO:4732 with a GF Score™ of 63/100 and a GF Value™ of NT$22.09 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Naturewise Biotech & Medicals's total equity for the quarter that ended in Dec. 2025 was NT$640.8 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Naturewise Biotech & Medicals Total Equity Historical Data

* Premium members only.

The historical data trend for Naturewise Biotech & Medicals's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Naturewise Biotech & Medicals Total Equity Chart

Naturewise Biotech & Medicals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 624.35 641.51 633.56 783.56 640.78

Naturewise Biotech & Medicals Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 633.56 641.93 783.56 718.64 640.78
ROCO:4732
63GF Score
Naturewise Biotech & Medicals Corp ROCO:4732
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Naturewise Biotech & Medicals Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Naturewise Biotech & Medicals's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=712.874-72.095
=640.8

Naturewise Biotech & Medicals's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=712.874-72.095
=640.8

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of NT$640.8 Mil mean?
Naturewise Biotech & Medicals (ROCO:4732) has a Total Equity of NT$640.8 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Naturewise Biotech & Medicals and its competitors.
Is Naturewise Biotech & Medicals' Total Equity too high?
Naturewise Biotech & Medicals' current Total Equity is NT$640.8 Mil. Overall, Naturewise Biotech & Medicals has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Naturewise Biotech & Medicals' Total Equity compare to VRTX and REGN?
Naturewise Biotech & Medicals' Total Equity of NT$640.8 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Naturewise Biotech & Medicals and its competitors. Naturewise Biotech & Medicals's current Total Equity is NT$640.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Naturewise Biotech & Medicals stock overvalued right now?
Based on GuruFocus' analysis, Naturewise Biotech & Medicals (ROCO:4732) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$22.09, compared to a current price of NT$17.30 — trading 21.7% below its estimated fair value. The current Total Equity is NT$640.8 Mil. Naturewise Biotech & Medicals' overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Naturewise Biotech & Medicals (ROCO:4732), the current Total Equity is NT$640.8 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Naturewise Biotech & Medicals (ROCO:4732) Overvalued in 2026?

Based on GuruFocus' analysis, Naturewise Biotech & Medicals stock appears to be undervalued. The current stock price of NT$17.30 is trading 21.7% below its estimated GF Value™ of NT$22.09. GuruFocus considers Naturewise Biotech & Medicals to be Modestly Undervalued.

Key valuation signals for ROCO:4732:

  • Total Equity: NT$640.8 Mil
  • GF Value™: NT$22.09 vs. price of NT$17.30 (21.7% below fair value)
  • GF Score™: 63/100 with 3 warning signs

No single metric tells the full story. See the ROCO:4732 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Naturewise Biotech & Medicals Business Description

Address No. 36, Bade Road, 6th Floor, Section 3, Songshan District, Taipei, TWN, 105
Naturewise Biotech & Medicals Corp is a Taiwan-based drug development company that focuses on botanical drug and small molecule therapies. Its products include NBM-BMX Oral Softgel Capsule, Lipocol Forte Capsule, and PPLs Taiwan Green Propolis.
63GF Score

Get the complete analysis for ROCO:4732

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$17.30
Price
NT$22.09
GF Value